Search filters

List of works by Georg Greiner

CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosis.

scientific article published on 16 November 2016

CD52 is a molecular target in advanced systemic mastocytosis.

scientific article published on 23 April 2014

Chloroquine inhibits human CD4+ T-cell activation by AP-1 signaling modulation.

scientific article published on 07 February 2017

Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis

scientific article published on 02 January 2021

Clonal Hematopoiesis of Indeterminate Potential: A Multidisciplinary Challenge in Personalized Hematology

scientific article published on 20 August 2020

Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia

scientific article published on 8 June 2017

Comparison of BCR-ABL1 quantification in peripheral blood and bone marrow using an International Scale-standardized assay for assessment of deep molecular response in chronic myeloid leukemia

scientific article published on 22 February 2020

Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms

scientific article

Development of a fully automated high throughput PCR for the detection of SARS-CoV-2: The need for speed

scientific article published on 01 December 2020

Digital PCR: A Sensitive and Precise Method for KIT D816V Quantification in Mastocytosis

scientific article

Expansion of BCR/ABL1+ cells requires PAK2 but not PAK1.

scientific article published on 14 July 2017

Fasting metabolism modulates the interleukin-12/interleukin-10 cytokine axis.

scientific article

Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML.

scientific article published on 25 November 2015

The JAK2 blocker TG101209 is a potent inhibitor of clonogenic progenitor cell growth in patients with chronic myeloid leukaemia

scientific article published on 21 February 2017

The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease

scientific article published on 17 April 2014

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.

scientific article published on 8 February 2018

The tryptophan metabolite picolinic acid suppresses proliferation and metabolic activity of CD4+ T cells and inhibits c-Myc activation.

scientific article published on 23 October 2015